Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

CD44 variant changes start alopecia areata, but don't maintain it.

IL-18 signaling helps mature Tregs move into the thymus.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

B cells can both help and hinder the body's defense against melanoma.

Targeting CD169+ skin macrophages may help treat psoriasis.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

CD90 is abundantly present on stem-like cells in dog hair follicles.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

The Fas/FasL pathway may play a role in alopecia areata.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

The role of γδT-cells in causing alopecia areata remains unclear.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

CS12192 effectively treats alopecia areata with better safety than current options.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

CD34 marks potential stem cells in dog hair follicles.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.